tiprankstipranks

Helen Kurincic Insider Profile

4 Followers
Helen Kurincic, Director at Integral Diagnostics Ltd., holds 25.00K shares in Mcmillan Shakespeare Limited (Ticker: DE:NMN), holds 555.58K shares in Integral Diagnostics Ltd. (Ticker: AU:IDX), holds 50.00K shares in Estia Health Ltd. (Ticker: DE:26E). Most recently, Helen Kurincic Bought ― shares of Mcmillan Shakespeare Limited on Nov 29, 2022 for an estimated value of 61.99K.
tipranks
Helen  Kurincic

Helen Kurincic
Integral Diagnostics Ltd. (IDX)
Director

Ranked #25,557 out of 98,564 Corporate Insiders

Profitable Transactions

63%
5 out of 8 Profitable Transactions

Average Return

+5.40%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

€1M
83.31%
16.69%
A breakdown of Helen Kurincic's holdings

Insider Roles

Integral Diagnostics Ltd.
(IDX)
Director
Mcmillan Shakespeare Limited
(NMN)
Director
Roles that Helen Kurincic holds in companies

Most Profitable Insider Trade

Stock:
Mcmillan Shakespeare Limited
(NMN)
Rating:Informative Buy
Date:Nov 07, 2022 - Nov 07, 2023
Return:+33.40%
The most profitable trade made by Helen Kurincic

Helen Kurincic's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Integral Diagnostics Ltd.
Mar 28, 2022
Director
Informative Buy
218.42K
AU$1.42M
26E
Estia Health Ltd.
Mar 04, 2020
Informative Buy
45.75K
€91.45K
Mcmillan Shakespeare Limited
Nov 29, 2022
Director
Informative Buy
61.99K
€285.00K
List of latest transactions for each holding click on a transaction to see Helen Kurincic's performance on stock

Helen Kurincic insider profile FAQ

What is the percentage of profitable transactions made by Helen Kurincic?
The percentage of profitable transactions made by Helen Kurincic is 63%.
    What is the average return per transaction made by Helen Kurincic?
    The average return per transaction made by Helen Kurincic is 5.40%.
      What stocks does Helen Kurincic hold?
      Helen Kurincic holds: AU:IDX, DE:26E, DE:NMN stocks.
        What was Helen Kurincic’s latest transaction?
        Helen Kurincic latest transaction was an Informative Buy of €61.99K.
          What was Helen Kurincic's most profitable transaction?
          Helen Kurincic’s most profitable transaction was an Informative Buy of DE:NMN stock on November 7, 2022. The return on the trade was 33.40%.
            What is Helen Kurincic's role in Integral Diagnostics Ltd.?
            Helen Kurincic's role in Integral Diagnostics Ltd. is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.